Reaction

Costochondritis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,611 reports · 23 co-occurring drugs

As of the last recalculation, Costochondritis appears in 1,611 FAERS reports alongside 23 co-occurring drug terms. The strongest observed disproportionality signal is ETONOGESTREL AND ETHINYL ESTRADIOL (PRR 23.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Etonogestrel And Ethinyl Estradiol4023.923.9
Butalbital, Acetaminophen, And Caffeine1417.117.1
Hyoscyamine Sulfate1115.615.6
Captopril912.212.2
Siponimod811.611.6
Magnesium Hydroxide1211.611.6
Naproxen6511.111.1
Methocarbamol Tablets1410.910.9
Cholestyramine1010.710.8
Niacin910.110.1
Methocarbamol179.89.8
Meclizine129.69.6
Human Insulin88.38.3
Sulfasalazine488.18.1
Ziprasidone Mesylate76.46.4
Calcium, Magnesium, Potassium, And Sodium Oxybates46.06.0
Secukinumab594.94.9
Elexacaftor, Tezacaftor, And Ivacaftor44.24.2
Conjugated Estrogens And Medroxyprogesterone Acetate73.83.8
Isotretinoin133.43.4
Drospirenone And Ethinyl Estradiol102.92.9
Hydrocodone Bitartrate82.42.4
Voxelotor31.71.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.